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Development of an invasively monitored porcine
model of acetaminophen-induced acute
liver failure
Philip N Newsome1,2*, Neil C Henderson2, Leonard J Nelson2, Costas Dabos2, Celine Filippi2, Chris Bellamy3,
Forbes Howie4, Richard E Clutton5, Tim King6, Alistair Lee, Peter C Hayes2, John N Plevris2
Abstract
Background: The development of effective therapies for acute liver failure (ALF) is limited by our knowledge of
the pathophysiology of this condition, and the lack of suitable large animal models of acetaminophen toxicity. Our
aim was to develop a reproducible invasively-monitored porcine model of acetaminophen-induced ALF.
Method: 35kg pigs were maintained under general anaesthesia and invasively monitored. Control pigs received a
saline infusion, whereas ALF pigs received acetaminophen intravenously for 12 hours to maintain blood
concentrations between 200-300 mg/l. Animals surviving 28 hours were euthanased.
Results: Cytochrome p450 levels in phenobarbital pre-treated animals were significantly higher than non pre-
treated animals (300 vs 100 pmol/mg protein). Control pigs (n = 4) survived 28-hour anaesthesia without incident.
Of nine pigs that received acetaminophen, four survived 20 hours and two survived 28 hours. Injured animals
developed hypotension (mean arterial pressure; 40.8 +/- 5.9 vs 59 +/- 2.0 mmHg), increased cardiac output (7.26
+/- 1.86 vs 3.30 +/- 0.40 l/min) and decreased systemic vascular resistance (8.48 +/- 2.75 vs 16.2 +/- 1.76 mPa/s/
m3). Dyspnoea developed as liver injury progressed and the increased pulmonary vascular resistance (636 +/- 95 vs
301 +/- 26.9 mPa/s/m3) observed may reflect the development of respiratory distress syndrome.
Liver damage was confirmed by deterioration in pH (7.23 +/- 0.05 vs 7.45 +/- 0.02) and prothrombin time (36 +/- 2
vs 8.9 +/- 0.3 seconds) compared with controls. Factor V and VII levels were reduced to 9.3 and 15.5% of starting
values in injured animals. A marked increase in serum AST (471.5 +/- 210 vs 42 +/- 8.14) coincided with a marked
reduction in serum albumin (11.5 +/- 1.71 vs 25 +/- 1 g/dL) in injured animals. Animals displayed evidence of renal
impairment; mean creatinine levels 280.2 +/- 36.5 vs 131.6 +/- 9.33 μmol/l. Liver histology revealed evidence of
severe centrilobular necrosis with coagulative necrosis. Marked renal tubular necrosis was also seen. Methaemoglo-
bin levels did not rise >5%. Intracranial hypertension was not seen (ICP monitoring), but there was biochemical evi-
dence of encephalopathy by the reduction of Fischer’s ratio from 5.6 +/- 1.1 to 0.45 +/- 0.06.
Conclusion: We have developed a reproducible large animal model of acetaminophen-induced liver failure, which
allows in-depth investigation of the pathophysiological basis of this condition. Furthermore, this represents an
important large animal model for testing artificial liver support systems.
Background
Acute liver failure (ALF) is a dramatic clinical syndrome
that results from massive hepatic necrosis. The mortality
of ALF remains high despite progress in the fields of
intensive care management and liver transplantation [1].
ALF refers to the rapid development of severe acute
liver injury with impaired synthetic function and ence-
phalopathy in subjects with previously normal, or well-
compensated liver disease [2]. Generation of a suitable
animal model would allow for a greater understanding
of the underlying pathophysiology of this condition and
stimulate the development and refinement of treatments
for ALF. There is a need for a suitable large animal
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model of hepatic injury to facilitate the development of
bio-artificial liver support systems in humans and to
assist pre-clinical assessment [3].
Since the recognition of acetaminophen-induced ALF in
the 1960s, acetaminophen overdose has become the com-
monest cause of liver failure in the United Kingdom [4].
Although an effective antidote (N-acetylcysteine) has been
available for many years, the late presentation of many
cases ensures a significant number develop liver failure.
Early large animal models of acetaminophen toxicity were
unreliable, producing inconsistent toxicity from animal to
animal. Gazzard et al [5] showed that dogs receiving oral
doses greater than 1 g/kg died of nonhepatic causes,
becoming cyanotic immediately before death with methy-
lene blue-resistant methaemoglobinaemia. Human studies
have shown that serum acetaminophen levels must be
>140 mg/mL for greater than 20 hours for consistent
hepatic necrosis to occur [6]. Using this, Francavilla et al
[7] studied various doses and dosing schedules on 52 bea-
gle dogs. These initially received 750 mg/kg acetamino-
phen subcutaneously followed by 200 mg/kg nine hours
later, and then a further 200 mg/kg twenty-four hours
later. Mortality rates in this group were: 0% at 24 hours,
10% at 48 hours, and 90% at 72 hours. Serum transami-
nase levels were greatly increased to 8206 +/- 3000 U/L at
48 hours and 21 253 +/- 3746 U/L at 72 hours. This corre-
lated with liver biopsy samples that revealed severe centri-
lobular necrosis.
Several approaches have been adopted to control
methaemoglobinaemia in animal models: Kelly et al [8]
using dogs, suspected high plasma acetaminophen levels
were responsible for the lethal methaemoglobinaemia
that characterised their early experiments. They con-
trolled acetaminophen infusion in an attempt to main-
tain its levels at 175 to 200 mg/mL for the first 20
hours. Methylene blue was administered at 10 mg/kg if
blood samples appeared brown on visual inspection.
Pilot data showed that levels of acetaminophen greater
than 300 mg/mL were associated with severe
methemoglobinemia.
Cellular glutathione (GSH) levels must be depleted to
approximately 20% of their original levels before toxic
acetaminophen damage can occur, [9,10]. To reduce
variation in the acetaminophen dose required and the
time taken for the development of signs, Kelly et al [8]
attempted to deplete GSH levels by administering
2 mmol/kg of buthionine sulfoximine (BSO) 2 hours
before acetaminophen. BSO [11], an analogue for glu-
tathione synthetase, binds and irreversibly inactivates
this enzyme which is the final enzyme in GSH synthesis.
The rapid turnover of cellular GSH, ensures that
enzyme inactivation leads to a rapid reduction in the
hepatocyte GSH concentrations. Kelly et al [8] showed
that BSO administration to mice decreased hepatic GSH
stores to 15% to 20% of normal within 2 hours. They
showed greater liver damage in the BSO group in terms
of alanine aminotransferase activity, prothrombin time,
bilirubin level, and histological characteristics. Miller
et al [12] administered phenobarbital to induce cyto-
chrome P-450 enzymes and thus potentiate subsequent
acetaminophen toxicity. This increased liver damage and
decreased animal survival.
There has been limited success in the development of
suitable large animal models of acetaminophen induced
liver injury. In the study described here we used bed-
side biochemical and invasive haemodynamic monitor-
ing during acetaminophen-induced liver damage in a
reproducible and controlled manner. Using this
approach we markedly reduced previously reported pro-
blems, i.e., methaemoglobinaemia and cardiovascular
collapse, and produced a large animal model which reli-
ably reproduces the syndrome of ALF observed in clini-
cal practice.
Methods
Animal experiments were performed in accordance with
the Home Office regulations under the Animal (Scienti-
fic Procedures) Act 1986 as per Project licence 60/2389.
All animals received humane care and study protocols
complied with our institution’s guidelines.
13 Large White pigs (median body mass 35 kg) were
maintained under. Anaesthesia was induced with Keta-
mine and Midazolam, and subsequently maintained with
isoflurane and nitrous oxide according to tidal volume.
Background hydration was maintained at a rate of
2 mls/kg/hr using a combination of 0.9% Normal Saline
and 5% Dextrose according to electrolyte results from
arterial blood gas sampling and urine output. Boluses of
colloid (Gelofusine) were administered for episodes of
hypotension. Heater pads were used to ensure that core
(rectal) temperature was maintained between 37-39°C
(the normal temperature range for pigs) [13]. Haemody-
namic variables were monitored continuously using a
Datex AS/3 monitoring system (Datex Ohmeda, Stirling,
UK) and recorded at one minute intervals using the
Datex Collect programme on a laptop computer. Mea-
surements were made from arterial, central venous and
pulmonary arterial cannulae. The latter allowed hourly
left atrial pressure (from pulmonary capillary wedge
pressure) and cardiac output (thermodilution) measure-
ments: 10 mls isotonic saline aliquots at 4°C were
injected through the injectate port of the pulmonary
artery catheter using a closed injectate system (CO-Set
plus, Baxter Edwards Critical Care, Irvine, CA, USA).
Three measurements were made at random points dur-
ing the respiratory cycle and an average value taken for
each measurement. Intracranial pressure (ICP) was
monitored with a subdural pressure transducer (Camino
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110-4B, Integra Lifesciences Corp, New Jersey, USA).
Correct positioning was confirmed by obtaining an
appropriate waveform that fluctuated with ventilation.
Urine output was monitored via a urethrostomy. Micro-
biological testing was performed routinely for all
animals.
Acetaminophen administration
All animals were pre-treated with phenobarbital 20 ml
orally per day for 5 days prior to each experiment to
induce cytochrome p450 enzymes (n = 13 pigs). Total
cytochrome p450 levels were measured using CO differ-
ence spectroscopy of sodium hydrosulphite samples
[14]. In nine animals intravenous acetaminophen was
administered while four animals were used as controls
and monitored invasively but did not receive any aceta-
minophen infusions. An initial loading dose of acetami-
nophen was administered by intravenous infusion
(0.1875 g/kg) followed by an infusion for 12 hours (1.8
mg/kg/min) with the intention of keeping blood aceta-
minophen concentration between 200-300 mg/l (n = 9
pigs). Acetaminophen levels were monitored by bed-side
testing using the Acetasite system (Indiana, USA). Arter-
ial blood gas and lactate levels were measured using a
Hewlett Packard I-Stat point-of-care blood analysis sys-
tem. Methaemoglobin was concurrently measured spec-
trophotometrically as previously described [15].
Experiments lasted up to 28 hours, and any animals
surviving at this time-point were euthanased. Necropsy
samples of liver, kidney and brain were then taken. Sam-
ples were fixed in formalin and embedded in paraffin.
Sections were cut at 5 microns and haematoxylin &
eosin stained for routine histological analysis.
Laboratory measurements
Standard laboratory assays were used for the measure-
ment of liver and renal function, full blood count and
coagulation parameters (prothrombin time, factors V,
VII, VIII). Serum aspartate aminotransferase, albumin,
potassium and creatinine analysis were measured on an
Olympus AU2700 automated analyser (Olympus UK
Ltd, Watford, UK.) using proprietary diagnostic kits.
NMR spectroscopy
NMR spectroscopy was used to measure a number of
amino acids in serum to calculate Fischer’s ratio [16],
which is the ratio of the aromatic amino acids (tyro-
sine and phenylalanine) to branch chain amino acids
(leucine, isoleucine and valine). Reversal of Fischer’s
ratio is a reliable marker of development of encephalo-
pathy in an anaesthetised model. Samples for NMR
spectroscopy were prepared and analysed as described
previously [17].
Statistical analysis
Results are presented as means ± S.E.M, as analysis
demonstrated the data to be normally distributed. Sig-
nificance of the differences between means was assessed
using the two-sided t test. Two-sided t test was per-
formed to determine the statistical difference after 24
hours between the two groups. Values of p < 0.05 were
considered significant.
Results
Cytochrome p450 levels measured in homogenised liver
tissue from phenobarbital pre-treated animals (n = 3
pigs)were significantly higher than in animals which had
not received phenobarbital (300 +/- 86 vs 100 +/- 31,
p = 0.01) pmol/mg protein. All animals in this study
subsequently received phenobarbital
Acetaminophen toxicity and methaemoglobinaemia
Acetaminophen was administered by intravenous infu-
sion for 12 hours with the intention of maintaining
blood levels between 200-300 mg/l. By accurate moni-
toring of acetaminophen and methaemoglobin levels
this was largely accomplished (figure 1a) although in
two (of nine) animals levels exceeded 400 mg/l. The
consequence of high acetaminophen levels, namely an
increasing methaemoglobin percentage, is demonstrated
in figure 1b. In injury 7 we were unable to measure
acetaminophen levels, and despite following a previously
calculated infusion pattern the pig developed severe
methaemoglobinaemia (peak of 13%). This reinforces
the importance of close monitoring of acetaminophen
levels. In general, methaemoglobinaemia (>4%) occurred
approximately 2-3 hours after acetaminophen levels
exceeded 350 mg/l. The finding of other groups, i.e.,
that brown blood discolouration presages the develop-
ment of methaemoglobinaemia was not confirmed in
the current study. Similarly the use of methylene blue
(MB) which has previously been described as an effec-
tive treatment for methaemoglobinaemia, was associated
with death within 5 minutes of injection in the
single animal of the current study in which it was
administered.
Animal survival
Control pigs (n = 4) survived the 28 hour anaesthetic
without complications, whilst only two of the nine
injured pigs survived to this time-point (see Figure 2a).
Two of the animals which received acetaminophen were
critically unwell, and were euthanased at 25 hours.
Three pigs developed a syndrome of multi-organ failure
(MOF) before death, which is in keeping with the clini-
cal condition [4]. Failure of two or more organ systems
was required for MOF to be confirmed: most commonly
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these were arterial hypotension (refractory to fluid
resuscitation) and ventilatory failure. Sepsis was con-
firmed in two pigs by blood culture (Klebsiella pneumo-
niae and Pseudomonas paucimobilis). Refractory
hypotension and/or difficulties in ensuring successful
ventilation led to a joint decision to euthanase pigs.
Cardio respiratory evaluation
Figures 3a and 3b demonstrate that injured pigs (as
opposed to uninjured pigs) developed the typical haemo-
dynamic pattern of acute liver injury characterised by
arterial hypotension (40.8 ± 5.9 vs 59 ± 2.0 mmHg, p =
0.16) (MAP, mean arterial pressure), increased cardiac
output (CO) (7.26 ± 1.86 vs 3.30 ± 0.40 l/min, p = 0.01)
and decreased systemic vascular resistance (SVR) (8.48 ±
2.75 vs 16.2 ± 1.76 mPa·s/m3, p = 0.03) that was unrespon-
sive to fluid infused in an attempt to maintain normal pul-
monary arterial occlusion pressures (PAOP) (figure 4).
Positive pressure lung ventilation was associated with a
reduction in total compliance as injury progressed and the
pulmonary vascular resistance (PVR) (636 ± 95 vs 301 ±
26.9 mPa·s/m3, p < 0.01) increased in this group (figure 4).
This may have indicated the onset of an adult respiratory
distress syndrome (ARDS)-like picture.
Laboratory analysis
Biochemical analysis revealed a marked increase in
serum AST (471.5 ± 210 vs 42 ± 8.14, p = 0.03) in
Figure 1 Acetaminophen concentrations (A) and Methaemoglobin levels (B) in pigs following acetaminophen administration. Panel A.
Acetaminophen levels for individual pigs are noted, with the corresponding methaemoglobin levels illustrated in panel B. Acetaminophen levels
of between 200 300 mg/l were aimed for although even with frequent measurements and reductions in the infusion rate there were rises often
to 400 mg/l. Prolonged elevation of levels above 300 mg/l did lead to a rise in methaemoglobin. For pig 7 facilities to measure acetaminophen
levels were unavailable and this led to a marked rise in methaemoglobin levels.
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conjunction with a marked reduction in serum albu-
min (11.5 ± 1.71 vs 25 ± 1 g/dL, p = 0.03) in injured
animals (figure 5a). AST rather than ALT was used to
quantify liver damage as the assay employed was
unable to measure porcine ALT from homogenised
porcine liver tissue. This hepatic dysfunction was con-
firmed by pH (7.23 ± 0.05 vs 7.45 ± 0.02, p = 0.02)
and prothrombin time (36 ± 2 vs 8.87 ± 0.33 seconds,
p = 0.002) (figure 5b). Arterial pH decreased signifi-
cantly in the injured group in parallel with increasing
prothrombin times (to a mean of 36 seconds at 24
hours). The liver components of prothrombin time,
factors V and VII were (figure 6a) to decrease after
injury to levels of 9.3% and 15.5% of normal values
respectively. Factor VIII levels remained unchanged
indicating that Disseminated intravascular coagulation
Figure 2 Kaplan Meier survival curve for control and acetaminophen injured pigs. (A) The control group (Group 0) as demonstrated by
the uninterrupted line all survived, and indeed appeared healthy when euthanased. The injury group (Group 1) as demonstrated by the
interrupted line died as denoted in the Kaplan-Meier curve. Two animals* were euthanased at 25 hours as they appeared particularly unwell, and
another further two were euthanased at the end of the experiment with no obvious ill effects from acetaminophen administration. (B) This table
outlines the likeliest cause of death along with a correlation with the amount of liver and renal injury. In most cases the cause of death was
multi-organ failure (MOF) with evidence of hypotension, marked oedema, oliguria and ventilatory difficulties. In two animals organisms were
identified in routine blood cultures. In pig 2 a cavitating lung abscess was identified although this was in addition to liver and renal injury.
However in pig 9 Pseudomonas paucimobilis was identified in blood cultures with little evidence of significant renal or liver damage. +++
covered severe hepatic coagulative necrosis, ++ covered moderate hepatic coagulative necrosis and + covered mild hepatic coagulative
necrosis. Similarly the scoring scale for renal injury covered the range from mild (+) to moderate (++) to severe (+++) tubular necrosis. Pig 7
developed significant methaemoglobinaemia (>10%). Administration of Methylene blue led to circulatory collapse and death within 5 minutes.
Pig 8 had moderately elevated levels of methaemoglobinaemia (>4%), and shortly before death dropped its oxygen saturations to 40%. No
additional contributory cause to death was identified.
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(DIC) was not the main cause for the altered levels of
other coagulation factors.
In addition to liver injury there was evidence of renal
impairment as shown in figure 7 where serum creatinine
rises above 250 μmol/l in injured animals, although
serum potassium remains below 6 mmol/l. Mean levels
of creatinine and potassium were 280.2 ± 36.5 vs 131.6
± 9.33 μmol/l (p = 0.002) and 5.65 ± 0.53 vs 4.6 ± 0.12
mmol/L (p = 0.27) respectively.
Evidence of encephalopathy: Fischer’s ratio
In the liver injury group there was a significant increase in
tyrosine (0.03 ± 0.004 vs 0.40 ± 0.02) (p < 0.008) and phe-
nylalanine concentrations (0.05 ± 0.004 vs 0.71 ± 0.08) (p
< 0.001) by the end of the experiment. There were no
statistically significant changes in leucine levels (0.17 ±
0.02 vs 0.175 ± 0.02) although isoleucine increased signifi-
cantly (0.08 ± 0.01 vs 0.2 ± 0.01) (p < 0.05) while valine
levels decreased (0.2 ± 0.02 vs 0.13 ± 0.01) (p < 0.01).
Fischer’s ratio (BCAA/AAA) was 5.6 ± 1.1 at the begin-
ning and 0.45 ± 0.06 at the end of the study (see Figure 8).
The ratio was unchanged in uninjured pigs.
Intracranial pressure (ICP) measurements
Intracranial pressure did not alter in any of the control
or injured animals at any time during the experiment.
Mean levels were 8 mmHg. Cerebral perfusion pressure
was less in injured animals, principally because of arter-
ial hypotension; this was not associated with obvious
cerebral histopathology.
Figure 3 Profile of Pulse, Mean Arterial pressure, Cardiac Output and Systemic Vascular Resistance in control and acetaminophen
injured pigs. Chart A demonstrates a progressive increase in pulse and concomitant reduction in MAP following liver injury. Furthermore, chart
B demonstrates a marked increase in cardiac output (CO) and decreased systemic vascular resistance (SVR) following liver injury. These
haemodynamic changes are in keeping with the multi-organ failure seen in acute liver injury.
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Histology
Histological analysis of liver tissue revealed perivenular
and mid-zone confluent hepatocytic necrosis in the
worst-affected animals, with microvesicular change in
preserved viable parenchyma. Other animals developed
less injury as judged by the extent of necrosis, but quali-
tatively similar patterns (see Figure 9) were seen. Four
animals demonstrated moderately severe liver injury, 2
developed severe coagulative necrosis and 3 developed
mild (no zonal confluent necrosis) liver injury. Similarly,
renal histopathology of seven pigs revealed severe acute
tubular injury as judged by the prevalence of vacuolar
change to the cortical tubular epithelium.
Discussion and Conclusions
The major role for an ALF model is to provide a more
controlled experimental environment than currently
exists [18]. An ideal model should satisfy the following
criteria: 1) induced hepatic failure should be reversible;
2) the features of liver damage should be reproducible;
3) selective damage should lead to fatal liver failure over
a period similar to that encountered in the human
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condition; but 4) with sufficient time to allow the option
for successful treatment; 5) the model should be large
enough to accommodate anthropocentric therapies; and
6) the toxins used should not be hazardous to laboratory
personnel. A pig model would be preferable as it has the
potential to fulfil all of these criteria, and also impor-
tantly shares very similar liver metabolic function with
human liver [19].
The porcine model described here develops most of
the signs typifying acute liver injury/failure, namely:
tachycardia, hypotension, increased cardiac output,
decreased systemic vascular resistance, coagulopathy,
renal failure and altered hepatic biochemistry. Conse-
quently, it is the only animal model of acetaminophen-
induced liver injury large enough to allow monitoring at
a level equivalent to intensive care. Whilst the outcome
of acetaminophen-injured pigs is relatively reproducible
there still remain some inherent variations highlighting
the difficulty of such studies. This reinforces the need to
perform large studies when using such animals to
ensure that individual variations can be accounted for.
Our model showed the typical increase in cardiac out-
put and reciprocal reductions in SVR found in the clini-
cal setting. Of note this is accelerated within the porcine
model, starting within 16 hours of the onset of liver
damage. This is likely a reflection of pre-treatment with
phenobarbitone. The increased PVR in the context of
normal PaO2 values was in keeping with the increased
requirement for positive end-expiration pressure (PEEP)
during ventilation. This may have indicated the onset of
an ARDS-like picture, although lung histology would be
important to support this conclusion. That PAOP did
Figure 5 Profile of serum AST, serum Albumin, arterial pH and plasma Prothrombin time in control and acetaminophen injured pigs.
Panel A depicts the increase in serum AST and concomitant reduction in serum albumin in acetaminophen injured pigs. This pattern of liver
injury was also seen in panel B, where arterial pH drops and Prothrombin time increases.
Newsome et al. BMC Gastroenterology 2010, 10:34
http://www.biomedcentral.com/1471-230X/10/34
Page 8 of 13
not increase suggests that the ventilatory changes were
not associated with pulmonary oedema secondary to left
ventricular failure. A non-significant reduction in PVR
Index after liver injury has been described [20]. The rea-
son for this difference is unclear. Acute lung injury is
common in patients with acetaminophen-induced fulmi-
nant hepatic failure and is associated with systemic cir-
culatory failure, cerebral oedema and high mortality.
The marked reduction in Factor V and VII levels in
the current model were consistent with severe liver
injury. The Clichy criteria [21] deemed a reduction of
Factor V levels to <20-30% as the trigger for liver trans-
plantation; this was the case in most animals in this
experiment. The absence of changes in Factor VIII levels
indicate DIC was not the cause of altered levels of other
coagulation factors.
An increase in AST levels indicated the development of
liver necrosis, although these were not as high as are seen
in patients. Similarly, a rise in bilirubin did not occur. This
may reflect a species-specificity of the assay used, or insuf-
ficient time for bilirubin to rise. It is possible that there are
subtle variations in this model compared to humans in
that some systemic features prevail over a liver focused
pattern of injury. Liver tissue analysis revealed severe coa-
gulative necrosis in some animals with moderate and mild
injury in others. This supports the probability that signifi-
cant liver injury accounts for the clinical syndrome
reported here. Although there is some variability in the
liver injury seen in this model, there is still significant liver
injury in the majority of animals. Indeed, this variation clo-
sely mimics what is seen clinically.
There are several explanations for the failure to observe
changes in ICP. The time course may have been too brief.
However, a raised ICP is not always encountered in the
clinical setting, or only in association with other factors
such as sepsis. It may also reflect differences in the patho-
physiology of drug-induced ALF as opposed to ischaemic
models of ALF. Measurements of arterial ammonia, cere-
bral blood flow or the use of cerebral microdialysis may
help to clarify intracranial effects in future studies. Bio-
chemical analysis suggested that animals may have been
developing encephalopathy, although in the absence of
ICP changes and with general anaesthesia it is difficult to
be certain. Fischer’s ratio [16], the ratio of the aromatic
amino acid (AAA; tyrosine and phenylalanine) to branch
chain amino acid (BCAA; leucine, isoleucine and valine)
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concentrations has a value of 3 to 4 in clinical liver failure
but when this ratio is reversed and is in absolute figures
<1.4 then most patients develop hepatic encephalopathy.
There was evidence of marked renal impairment,
although fatal hyperkalaemia was not observed. Renal
dysfunction is an important feature of acetaminophen
induced liver failure [22], and the renal histology in trea-
ted animals was consistent with a toxic injury rather
than the distinctive pattern of frank outer medullary
tubular necrosis encountered with ischaemia, i.e., critical
hypotension.
Methaemoglobinaemia
This study demonstrates the importance of continuous
monitoring of acetaminophen levels, the one animal from
which it was withheld died from methaemoglobinaemia.
The amount of acetaminophen required to maintain
levels between 200-300 mg/l for 12 hours was calculated
Figure 9 Histology. This figure depicts representative photographs of liver and renal sections. Panel a, represents liver tissue taken from a
control pig. Panel b represents liver tissue taken from pig 4 and demonstrates moderate injury. There is diffuse microvesicular change, with
moderately severe centrilobular necrosis. Panels c and d (higher power) represents liver tissue taken from pig 7 demonstrating more severe
coagulative centrilobular necrosis. Panel e represents renal tissue taken from a control pig. Panel f represents liver tissue taken from pig 7
demonstrating severe vacuolar injury to the cortical tubules in keeping with the development of acute tubular necrosis.
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beforehand, but it was necessary in every case to reduce
the infusion rate (and the total dose administered) as
acetaminophen levels exceeded this range. Levels greater
than 250 mg/l increased serum methaemoglobin levels,
although this usually resolved by stopping the acetamino-
phen infusion which allowed plasma levels to fall. Aceta-
minophen and its intermediates oxidise haemoglobin to
methaemoglobin, which is unable to carry oxygen.
Although it occurs in human beings, it is less marked
than in cats, dogs, and pigs. In some species, methemo-
globin is reduced to hemoglobin by the methemoglobin
reductase using reduced glutathione (GHS) as a sub-
strate. GSH itself is recycled by the glutathione reductase,
using reduced nicotinamide-adenine dinucleotide phos-
phate (NADPH) from the pentose phosphate pathway.
Due to the glucose impermeability of porcine red blood
cells (compared with rats and rabbits) there is a diminu-
tion in generation of NADPH and hence decreased
reduction of methaemoglobin [23]. Levels of methaemo-
globinaemia in pigs [24] administered acetaminophen are
only one-half those reported in cats [25] and dogs [26].
There are several measures to control methaemoglobin
levels in animal models. Kelly et al [8] suspected high
plasma acetaminophen levels were responsible for lethal
methaemoglobinaemia and so tried to prevent them. Not
having access to bedside testing and thus being unable to
prevent high acetaminophen levels they administered MB
at 10 mg/kg if the blood appeared brown on visual
inspection. The usefulness of this strategy was not con-
firmed in the current study.
Methylene blue is the recognized clinical treatment
for methaemoglobinaemia and acts by reducing
methaemoglobin back to haemoglobin. Its action
depends on the availability of adequate NADPH con-
centrations within the erythrocyte; a deficiency of
NADPH availability leads to further methaemoglobi-
naemia. On the single occasion it was used in the cur-
rent study the animal died of cardiovascular collapse 5
minutes later.
Presence of anaemia
Miller et al [12] found that the haematocrit fell rapidly
(25% decrease from the initial packed cell volume) in
sixty percent of animals 1 to 2 hours before death. The
cause of anaemia in their study was unclear, and may
reflect extravascular haemolysis within the spleen. The
haemoglobin nor haematocrit levels did not fall in either
the control nor the treatment groups in the current
study.
In summary, we have described the first intensively
monitored porcine model of acetaminophen-induced
severe liver injury which displays most of the features
seen in the human condition. This large animal model
can play an important role in the evaluation of the
effectiveness of liver support systems, as well as provid-
ing us with the ability to develop a much better under-
standing of the pathophysiology of this devastating
clinical syndrome.
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